Table 4.
F1 scores for each respective model and outcome in a 1-month and 3-month follow-up period after participants’ initial onboarding.
| Outcome and model | F1 Score, % | ||
|
|
|
1-month follow-up | 3-month follow-up |
| HIVa |
|
|
|
|
|
Support vector machine | 70.5 | 81.6 |
|
|
Random forest | 73.4 | 82.6 |
|
|
Naïve Bayes | 69.6 | 82.1 |
|
|
Logistic regression | 68.5 | 81.4 |
| Amphetamines |
|
|
|
|
|
Support vector machine | 88.2 | 85.9 |
|
|
Random forest | 88.3 | 85.9 |
|
|
Naïve Bayes | 88.0 | 85.5 |
|
|
Logistic regression | 88.1 | 85.8 |
| Methamphetamines |
|
|
|
|
|
Support vector machine | 88.3 | 85.1 |
|
|
Random forest | 88.3 | 85.3 |
|
|
Naïve Bayes | 88.1 | 84.8 |
|
|
Logistic regression | 88.2 | 85.0 |
| THCb |
|
|
|
|
|
Support vector machine | 11.1 | 7.4 |
|
|
Random forest | 5.0 | 0.5 |
|
|
Naïve Bayes | 24.0 | 4.7 |
|
|
Logistic regression | 10.9 | 9.1 |
aHIV: human immunodeficiency virus.
bTHC: tetrahydrocannabinol.